Auna SA Hits New 52-Week Low at USD 4.27 Amid Market Struggles

Auna SA, a microcap company in the Pharmaceuticals & Biotechnology sector, has recently reached a new 52-week low of USD 4.27 on May 20, 2026. This decline marks a significant downturn for the stock, which has experienced a one-year performance drop of 32.03%. In comparison, the S&P 500 has shown a positive performance of 25.12% over the same period, highlighting Auna SA's struggles in the market. The company's market capitalization stands at USD 383 million, and it currently has a price-to-earnings (P/E) ratio of 7.00. However, Auna SA's return on equity is notably negative, indicating challenges in generating profits relative to shareholder equity. Additionally, the stock's price-to-book ratio is 0.80, suggesting that it is trading below its book value. Despite some positive results reported in January, the overall performance metrics indicate that Auna SA has faced difficulties both in the near term and over the long term. The stock's previous 52-week high was USD 6.98, further emphasizing the extent of its recent decline.